Detalles de la búsqueda
1.
Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 17(9): 1655-1668.e3, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30928454
2.
Appropriateness of Combination Therapy for Patients With Inflammatory Bowel Diseases: One Size Still Does Not Fit All.
Clin Gastroenterol Hepatol
; 16(11): 1829-1831, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29505910
3.
Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results.
Clin Gastroenterol Hepatol
; 14(9): 1302-9, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27189916
4.
Innovative Care for Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Use of Bedside Intestinal Ultrasound to Optimize Management.
J Can Assoc Gastroenterol
; 6(1): e1-e6, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36785574
5.
Assessment of variables associated with smoking cessation in Crohn's disease.
Dig Dis Sci
; 57(4): 1026-32, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22311366
6.
The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit all.
Clin Gastroenterol Hepatol
; 8(8): 655-9, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20451665
7.
Complementary and alternative medications in the management of inflammatory bowel disease.
Therap Adv Gastroenterol
; 13: 1756284820927550, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32523629
8.
Managing the risks of IBD therapy.
Curr Gastroenterol Rep
; 11(6): 509-17, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19903428
9.
Anti-aging therapy with human growth hormone associated with metastatic colon cancer in a patient with Crohn's colitis.
Clin Gastroenterol Hepatol
; 6(3): 360-3, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18255351
10.
Real-world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel disease.
Aliment Pharmacol Ther
; 48(6): 626-637, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30063077
11.
Preoperative Ustekinumab Treatment Is Not Associated With Increased Postoperative Complications in Crohn's Disease: A Canadian Multi-Centre Observational Cohort Study.
J Can Assoc Gastroenterol
; 1(3): 115-123, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31294352
12.
Long-term Maintenance of Clinical, Endoscopic, and Radiographic Response to Ustekinumab in Moderate-to-Severe Crohn's Disease: Real-world Experience from a Multicenter Cohort Study.
Inflamm Bowel Dis
; 23(5): 833-839, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28328624
13.
Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel.
Inflamm Bowel Dis
; 22(6): 1418-24, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27057680
14.
Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy.
Can J Gastroenterol
; 18(5): 321-6, 2004 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-15152283
15.
A survey of perceptions and practices of complementary alternative medicine among Canadian gastroenterologists.
Can J Gastroenterol Hepatol
; 28(1): 45-9, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24212913
16.
Canadian Association of Gastroenterology Position Statement: Use of Cannabis in Gastroenterological and Hepatic Disorders.
J Can Assoc Gastroenterol
; 2(1): 37-43, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31294362
17.
Defining quality indicators for best-practice management of inflammatory bowel disease in Canada.
Can J Gastroenterol Hepatol
; 28(5): 275-85, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24839622
18.
Determination of serologic and genetic markers aid in the determination of the clinical course and severity of patients with IBD.
Inflamm Bowel Dis
; 14(1): 125-8; discussion 132-3, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17932968
19.
Curry for the cure?
Inflamm Bowel Dis
; 13(12): 1576-7, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17663428
20.
Patient-specific approach to combination versus monotherapy with the use of antitumor necrosis factor α agents for inflammatory bowel disease.
Gastroenterol Clin North Am
; 41(2): 411-28, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22500526